Answers are grounded in this paper and cite their sources.
Since the original proposal of a two-signal model for lymphocyte activation (1), it has become firmly established that costimulatory signals mediated primarily via the conventional CD28-B7 and CD154-CD40 pathways, are necessary for full T-cell activation and play a crucial role in mediating allograft rejection (2). In several transplantation models, CD28-B7 or CD154-CD40 blockade has been shown to prevent acute rejection, induce long-term allograft survival and prevent the development and progression of chronic rejection.
No takes yet. Share an insight, caveat, or question.
Salama et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: